Seth Billiodeaux, MD
Pain Medicine · Lake Charles, LANPI 1841492196
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,590 of the $4,475 with a category attached, or 80.2%. 22 manufacturers reported payments, led by AbbVie at 40.8% of the total. 2025 is the largest year on record at $1,817, 7.1 times the $257 reported in 2019.
Across 223 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Spinal Simplicity, LLC$996
- Medtronic$422
- Boston Scientific$243
- Pacira Pharmaceuticals Incorporated$203
- Stryker$116
- plus $667 from 16 others
What the payments were for
- Travel & lodging$88620%
- Food & beverage$3,59080%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 130 | $1,828 |
| Spinal Simplicity, LLC | 14 | $996 |
| Medtronic | 24 | $422 |
| Boston Scientific | 11 | $243 |
| Pacira Pharmaceuticals Incorporated | 5 | $203 |
| Stryker | 4 | $116 |
| Nevro Corp. | 4 | $95 |
| Novartis | 6 | $86 |
| Hydrocision, Inc. | 1 | $71 |
| Lundbeck LLC | 3 | $64 |
| Abbott | 4 | $61 |
| Biohaven Pharmaceuticals, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Amgen | 3 | $39 |
| Smith+Nephew | 1 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Vertex | 1 | $16 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$758
- Iovera$128
How this compares
$4,475 in reported general payments places this provider in the 55th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amitriptyline Hcl | 11 | $192 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lake Charles
- Gassan ChaibanLake Charles$30K
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
- Derrick DeanTerrytown$68K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Yashar EshraghiNew Orleans$22K
- Prathima AnandiShreveport$19K
- Jason GremillionBaton Rouge$19K
- Eric StockwellMetairie$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.